7 assets in Lymphomatoid Papulosis

Therapeutic assets addressing Lymphomatoid Papulosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Brentuximab Vedotin Lymphomatoid Papulosis	Memorial Sloan Kettering Cancer Center	P2	B (57)
Atlcar.Cd30.Ccr4 Cells Lymphomatoid Papulosis	UNC Lineberger Comprehensive Cancer Center	P1	CC (43)
Bendamustine Lymphomatoid Papulosis	UNC Lineberger Comprehensive Cancer Center	P1	CC (43)
Fludarabine Lymphomatoid Papulosis	UNC Lineberger Comprehensive Cancer Center	P1	CC (43)
Bexarotene Lymphomatoid Papulosis	Case Comprehensive Cancer Center	N/A	D (30)
Kenacort Lymphomatoid Papulosis	Case Comprehensive Cancer Center	N/A	D (30)
Nitrogen Mustard Lymphomatoid Papulosis	Case Comprehensive Cancer Center	N/A	D (30)